aluates Reports

$ 0.0

Automative

Global Antisense and RNAi Therapeutics Drug Market Research Report 2025

Published Date: May 2025

Report Code: QYRE-Auto-25C13748

Global Antisense and RNAi Therapeutics Drug Market Research Report 2023

BUY CHAPTERS

Global Antisense and RNAi Therapeutics Drug Market Research Report 2025

Code: QYRE-Auto-25C13748

Report

May 2025

Pages:74

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Biogen

Sarepta Therapeutics

Jazz Pharmaceuticals

Bausch & Lomb

Alnylam Pharmaceuticals

Dynavax Technologies

Kastle therapeutics

Akcea Therapeutics

Antisense and RNAi Therapeutics Drug Market Size

The global market for Antisense and RNAi Therapeutics Drug was valued at US$ 918 million in the year 2024 and is projected to reach a revised size of US$ 1395 million by 2031, growing at a CAGR of 6.3% during the forecast period.

Antisense and RNAi Therapeutics Drug Market

Many pharmaceutical companies were conducting research on oligonucleotide therapy, which employs chemically synthesized nucleotide-like small molecule drugs with potential specificity similar to that of therapeutic antibodies.

North American market for Antisense and RNAi Therapeutics Drug is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Antisense and RNAi Therapeutics Drug is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The global market for Antisense and RNAi Therapeutics Drug in Neuromuscular Diseases is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global companies of Antisense and RNAi Therapeutics Drug include Biogen, Sarepta Therapeutics, Jazz Pharmaceuticals, Bausch & Lomb, Alnylam Pharmaceuticals, Dynavax Technologies, Kastle therapeutics, Akcea Therapeutics, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

This report aims to provide a comprehensive presentation of the global market for Antisense and RNAi Therapeutics Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Antisense and RNAi Therapeutics Drug.

The Antisense and RNAi Therapeutics Drug market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Antisense and RNAi Therapeutics Drug market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Antisense and RNAi Therapeutics Drug companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Antisense and RNAi Therapeutics Drug Market Report

Report Metric	Details
Report Name	Antisense and RNAi Therapeutics Drug Market
Accounted market size in year	US$ 918 million
Forecasted market size in 2031	US$ 1395 million
CAGR	6.3%
Base Year	year
Forecasted years	2025 - 2031
Segment by Type	Antisense Oligonucleotide Aptamer Other
Segment by Application	Neuromuscular Diseases ATTR Hepatic VOD Other
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Biogen, Sarepta Therapeutics, Jazz Pharmaceuticals, Bausch & Lomb, Alnylam Pharmaceuticals, Dynavax Technologies, Kastle therapeutics, Akcea Therapeutics
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Antisense and RNAi Therapeutics Drug company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Antisense and RNAi Therapeutics Drug Market growing?

Ans: The Antisense and RNAi Therapeutics Drug Market witnessing a CAGR of 6.3% during the forecast period 2025-2031.

What is the Antisense and RNAi Therapeutics Drug Market size in 2031?

Ans: The Antisense and RNAi Therapeutics Drug Market size in 2031 will be US$ 1395 million.

Who are the main players in the Antisense and RNAi Therapeutics Drug Market report?

Ans: The main players in the Antisense and RNAi Therapeutics Drug Market are Biogen, Sarepta Therapeutics, Jazz Pharmaceuticals, Bausch & Lomb, Alnylam Pharmaceuticals, Dynavax Technologies, Kastle therapeutics, Akcea Therapeutics

What are the Application segmentation covered in the Antisense and RNAi Therapeutics Drug Market report?

Ans: The Applications covered in the Antisense and RNAi Therapeutics Drug Market report are Neuromuscular Diseases, ATTR, Hepatic VOD, Other

What are the Type segmentation covered in the Antisense and RNAi Therapeutics Drug Market report?

Ans: The Types covered in the Antisense and RNAi Therapeutics Drug Market report are Antisense Oligonucleotide, Aptamer, Other

Recommended Reports

Gene and Cell Therapy

Oligonucleotide and RNA Market

RNAi and mRNA Therapeutics

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Antisense and RNAi Therapeutics Drug Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 Antisense Oligonucleotide

1.2.3 Aptamer

1.2.4 Other

1.3 Market by Application

1.3.1 Global Antisense and RNAi Therapeutics Drug Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Neuromuscular Diseases

1.3.3 ATTR

1.3.4 Hepatic VOD

1.3.5 Other

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Antisense and RNAi Therapeutics Drug Market Perspective (2020-2031)

2.2 Global Antisense and RNAi Therapeutics Drug Growth Trends by Region

2.2.1 Global Antisense and RNAi Therapeutics Drug Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Antisense and RNAi Therapeutics Drug Historic Market Size by Region (2020-2025)

2.2.3 Antisense and RNAi Therapeutics Drug Forecasted Market Size by Region (2026-2031)

2.3 Antisense and RNAi Therapeutics Drug Market Dynamics

2.3.1 Antisense and RNAi Therapeutics Drug Industry Trends

2.3.2 Antisense and RNAi Therapeutics Drug Market Drivers

2.3.3 Antisense and RNAi Therapeutics Drug Market Challenges

2.3.4 Antisense and RNAi Therapeutics Drug Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Antisense and RNAi Therapeutics Drug Players by Revenue

3.1.1 Global Top Antisense and RNAi Therapeutics Drug Players by Revenue (2020-2025)

3.1.2 Global Antisense and RNAi Therapeutics Drug Revenue Market Share by Players (2020-2025)

3.2 Global Antisense and RNAi Therapeutics Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Antisense and RNAi Therapeutics Drug Revenue

3.4 Global Antisense and RNAi Therapeutics Drug Market Concentration Ratio

3.4.1 Global Antisense and RNAi Therapeutics Drug Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Antisense and RNAi Therapeutics Drug Revenue in 2024

3.5 Global Key Players of Antisense and RNAi Therapeutics Drug Head office and Area Served

3.6 Global Key Players of Antisense and RNAi Therapeutics Drug, Product and Application

3.7 Global Key Players of Antisense and RNAi Therapeutics Drug, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Antisense and RNAi Therapeutics Drug Breakdown Data by Type

4.1 Global Antisense and RNAi Therapeutics Drug Historic Market Size by Type (2020-2025)

4.2 Global Antisense and RNAi Therapeutics Drug Forecasted Market Size by Type (2026-2031)

5 Antisense and RNAi Therapeutics Drug Breakdown Data by Application

5.1 Global Antisense and RNAi Therapeutics Drug Historic Market Size by Application (2020-2025)

5.2 Global Antisense and RNAi Therapeutics Drug Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America Antisense and RNAi Therapeutics Drug Market Size (2020-2031)

6.2 North America Antisense and RNAi Therapeutics Drug Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Antisense and RNAi Therapeutics Drug Market Size by Country (2020-2025)

6.4 North America Antisense and RNAi Therapeutics Drug Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Antisense and RNAi Therapeutics Drug Market Size (2020-2031)

7.2 Europe Antisense and RNAi Therapeutics Drug Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Antisense and RNAi Therapeutics Drug Market Size by Country (2020-2025)

7.4 Europe Antisense and RNAi Therapeutics Drug Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Antisense and RNAi Therapeutics Drug Market Size (2020-2031)

8.2 Asia-Pacific Antisense and RNAi Therapeutics Drug Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Antisense and RNAi Therapeutics Drug Market Size by Region (2020-2025)

8.4 Asia-Pacific Antisense and RNAi Therapeutics Drug Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Antisense and RNAi Therapeutics Drug Market Size (2020-2031)

9.2 Latin America Antisense and RNAi Therapeutics Drug Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Antisense and RNAi Therapeutics Drug Market Size by Country (2020-2025)

9.4 Latin America Antisense and RNAi Therapeutics Drug Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Antisense and RNAi Therapeutics Drug Market Size (2020-2031)

10.2 Middle East & Africa Antisense and RNAi Therapeutics Drug Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Antisense and RNAi Therapeutics Drug Market Size by Country (2020-2025)

10.4 Middle East & Africa Antisense and RNAi Therapeutics Drug Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Biogen

11.1.1 Biogen Company Details

11.1.2 Biogen Business Overview

11.1.3 Biogen Antisense and RNAi Therapeutics Drug Introduction

11.1.4 Biogen Revenue in Antisense and RNAi Therapeutics Drug Business (2020-2025)

11.1.5 Biogen Recent Development

11.2 Sarepta Therapeutics

11.2.1 Sarepta Therapeutics Company Details

11.2.2 Sarepta Therapeutics Business Overview

11.2.3 Sarepta Therapeutics Antisense and RNAi Therapeutics Drug Introduction

11.2.4 Sarepta Therapeutics Revenue in Antisense and RNAi Therapeutics Drug Business (2020-2025)

11.2.5 Sarepta Therapeutics Recent Development

11.3 Jazz Pharmaceuticals

11.3.1 Jazz Pharmaceuticals Company Details

11.3.2 Jazz Pharmaceuticals Business Overview

11.3.3 Jazz Pharmaceuticals Antisense and RNAi Therapeutics Drug Introduction

11.3.4 Jazz Pharmaceuticals Revenue in Antisense and RNAi Therapeutics Drug Business (2020-2025)

11.3.5 Jazz Pharmaceuticals Recent Development

11.4 Bausch & Lomb

11.4.1 Bausch & Lomb Company Details

11.4.2 Bausch & Lomb Business Overview

11.4.3 Bausch & Lomb Antisense and RNAi Therapeutics Drug Introduction

11.4.4 Bausch & Lomb Revenue in Antisense and RNAi Therapeutics Drug Business (2020-2025)

11.4.5 Bausch & Lomb Recent Development

11.5 Alnylam Pharmaceuticals

11.5.1 Alnylam Pharmaceuticals Company Details

11.5.2 Alnylam Pharmaceuticals Business Overview

11.5.3 Alnylam Pharmaceuticals Antisense and RNAi Therapeutics Drug Introduction

11.5.4 Alnylam Pharmaceuticals Revenue in Antisense and RNAi Therapeutics Drug Business (2020-2025)

11.5.5 Alnylam Pharmaceuticals Recent Development

11.6 Dynavax Technologies

11.6.1 Dynavax Technologies Company Details

11.6.2 Dynavax Technologies Business Overview

11.6.3 Dynavax Technologies Antisense and RNAi Therapeutics Drug Introduction

11.6.4 Dynavax Technologies Revenue in Antisense and RNAi Therapeutics Drug Business (2020-2025)

11.6.5 Dynavax Technologies Recent Development

11.7 Kastle therapeutics

11.7.1 Kastle therapeutics Company Details

11.7.2 Kastle therapeutics Business Overview

11.7.3 Kastle therapeutics Antisense and RNAi Therapeutics Drug Introduction

11.7.4 Kastle therapeutics Revenue in Antisense and RNAi Therapeutics Drug Business (2020-2025)

11.7.5 Kastle therapeutics Recent Development

11.8 Akcea Therapeutics

11.8.1 Akcea Therapeutics Company Details

11.8.2 Akcea Therapeutics Business Overview

11.8.3 Akcea Therapeutics Antisense and RNAi Therapeutics Drug Introduction

11.8.4 Akcea Therapeutics Revenue in Antisense and RNAi Therapeutics Drug Business (2020-2025)

11.8.5 Akcea Therapeutics Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Biogen

Sarepta Therapeutics

Jazz Pharmaceuticals

Bausch & Lomb

Alnylam Pharmaceuticals

Dynavax Technologies

Kastle therapeutics

Akcea Therapeutics

List of Tables

Table 1. Global Antisense and RNAi Therapeutics Drug Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of Antisense Oligonucleotide

Table 3. Key Players of Aptamer

Table 4. Key Players of Other

Table 5. Global Antisense and RNAi Therapeutics Drug Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 6. Global Antisense and RNAi Therapeutics Drug Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 7. Global Antisense and RNAi Therapeutics Drug Market Size by Region (2020-2025) & (US$ Million)

Table 8. Global Antisense and RNAi Therapeutics Drug Market Share by Region (2020-2025)

Table 9. Global Antisense and RNAi Therapeutics Drug Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 10. Global Antisense and RNAi Therapeutics Drug Market Share by Region (2026-2031)

Table 11. Antisense and RNAi Therapeutics Drug Market Trends

Table 12. Antisense and RNAi Therapeutics Drug Market Drivers

Table 13. Antisense and RNAi Therapeutics Drug Market Challenges

Table 14. Antisense and RNAi Therapeutics Drug Market Restraints

Table 15. Global Antisense and RNAi Therapeutics Drug Revenue by Players (2020-2025) & (US$ Million)

Table 16. Global Antisense and RNAi Therapeutics Drug Market Share by Players (2020-2025)

Table 17. Global Top Antisense and RNAi Therapeutics Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Antisense and RNAi Therapeutics Drug as of 2024)

Table 18. Ranking of Global Top Antisense and RNAi Therapeutics Drug Companies by Revenue (US$ Million) in 2024

Table 19. Global 5 Largest Players Market Share by Antisense and RNAi Therapeutics Drug Revenue (CR5 and HHI) & (2020-2025)

Table 20. Global Key Players of Antisense and RNAi Therapeutics Drug, Headquarters and Area Served

Table 21. Global Key Players of Antisense and RNAi Therapeutics Drug, Product and Application

Table 22. Global Key Players of Antisense and RNAi Therapeutics Drug, Date of Enter into This Industry

Table 23. Mergers & Acquisitions, Expansion Plans

Table 24. Global Antisense and RNAi Therapeutics Drug Market Size by Type (2020-2025) & (US$ Million)

Table 25. Global Antisense and RNAi Therapeutics Drug Revenue Market Share by Type (2020-2025)

Table 26. Global Antisense and RNAi Therapeutics Drug Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 27. Global Antisense and RNAi Therapeutics Drug Revenue Market Share by Type (2026-2031)

Table 28. Global Antisense and RNAi Therapeutics Drug Market Size by Application (2020-2025) & (US$ Million)

Table 29. Global Antisense and RNAi Therapeutics Drug Revenue Market Share by Application (2020-2025)

Table 30. Global Antisense and RNAi Therapeutics Drug Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 31. Global Antisense and RNAi Therapeutics Drug Revenue Market Share by Application (2026-2031)

Table 32. North America Antisense and RNAi Therapeutics Drug Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 33. North America Antisense and RNAi Therapeutics Drug Market Size by Country (2020-2025) & (US$ Million)

Table 34. North America Antisense and RNAi Therapeutics Drug Market Size by Country (2026-2031) & (US$ Million)

Table 35. Europe Antisense and RNAi Therapeutics Drug Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 36. Europe Antisense and RNAi Therapeutics Drug Market Size by Country (2020-2025) & (US$ Million)

Table 37. Europe Antisense and RNAi Therapeutics Drug Market Size by Country (2026-2031) & (US$ Million)

Table 38. Asia-Pacific Antisense and RNAi Therapeutics Drug Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 39. Asia-Pacific Antisense and RNAi Therapeutics Drug Market Size by Region (2020-2025) & (US$ Million)

Table 40. Asia-Pacific Antisense and RNAi Therapeutics Drug Market Size by Region (2026-2031) & (US$ Million)

Table 41. Latin America Antisense and RNAi Therapeutics Drug Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 42. Latin America Antisense and RNAi Therapeutics Drug Market Size by Country (2020-2025) & (US$ Million)

Table 43. Latin America Antisense and RNAi Therapeutics Drug Market Size by Country (2026-2031) & (US$ Million)

Table 44. Middle East & Africa Antisense and RNAi Therapeutics Drug Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 45. Middle East & Africa Antisense and RNAi Therapeutics Drug Market Size by Country (2020-2025) & (US$ Million)

Table 46. Middle East & Africa Antisense and RNAi Therapeutics Drug Market Size by Country (2026-2031) & (US$ Million)

Table 47. Biogen Company Details

Table 48. Biogen Business Overview

Table 49. Biogen Antisense and RNAi Therapeutics Drug Product

Table 50. Biogen Revenue in Antisense and RNAi Therapeutics Drug Business (2020-2025) & (US$ Million)

Table 51. Biogen Recent Development

Table 52. Sarepta Therapeutics Company Details

Table 53. Sarepta Therapeutics Business Overview

Table 54. Sarepta Therapeutics Antisense and RNAi Therapeutics Drug Product

Table 55. Sarepta Therapeutics Revenue in Antisense and RNAi Therapeutics Drug Business (2020-2025) & (US$ Million)

Table 56. Sarepta Therapeutics Recent Development

Table 57. Jazz Pharmaceuticals Company Details

Table 58. Jazz Pharmaceuticals Business Overview

Table 59. Jazz Pharmaceuticals Antisense and RNAi Therapeutics Drug Product

Table 60. Jazz Pharmaceuticals Revenue in Antisense and RNAi Therapeutics Drug Business (2020-2025) & (US$ Million)

Table 61. Jazz Pharmaceuticals Recent Development

Table 62. Bausch & Lomb Company Details

Table 63. Bausch & Lomb Business Overview

Table 64. Bausch & Lomb Antisense and RNAi Therapeutics Drug Product

Table 65. Bausch & Lomb Revenue in Antisense and RNAi Therapeutics Drug Business (2020-2025) & (US$ Million)

Table 66. Bausch & Lomb Recent Development

Table 67. Alnylam Pharmaceuticals Company Details

Table 68. Alnylam Pharmaceuticals Business Overview

Table 69. Alnylam Pharmaceuticals Antisense and RNAi Therapeutics Drug Product

Table 70. Alnylam Pharmaceuticals Revenue in Antisense and RNAi Therapeutics Drug Business (2020-2025) & (US$ Million)

Table 71. Alnylam Pharmaceuticals Recent Development

Table 72. Dynavax Technologies Company Details

Table 73. Dynavax Technologies Business Overview

Table 74. Dynavax Technologies Antisense and RNAi Therapeutics Drug Product

Table 75. Dynavax Technologies Revenue in Antisense and RNAi Therapeutics Drug Business (2020-2025) & (US$ Million)

Table 76. Dynavax Technologies Recent Development

Table 77. Kastle therapeutics Company Details

Table 78. Kastle therapeutics Business Overview

Table 79. Kastle therapeutics Antisense and RNAi Therapeutics Drug Product

Table 80. Kastle therapeutics Revenue in Antisense and RNAi Therapeutics Drug Business (2020-2025) & (US$ Million)

Table 81. Kastle therapeutics Recent Development

Table 82. Akcea Therapeutics Company Details

Table 83. Akcea Therapeutics Business Overview

Table 84. Akcea Therapeutics Antisense and RNAi Therapeutics Drug Product

Table 85. Akcea Therapeutics Revenue in Antisense and RNAi Therapeutics Drug Business (2020-2025) & (US$ Million)

Table 86. Akcea Therapeutics Recent Development

Table 87. Research Programs/Design for This Report

Table 88. Key Data Information from Secondary Sources

Table 89. Key Data Information from Primary Sources

Table 90. Authors List of This Report

List of Figures

Figure 1. Antisense and RNAi Therapeutics Drug Picture

Figure 2. Global Antisense and RNAi Therapeutics Drug Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Antisense and RNAi Therapeutics Drug Market Share by Type: 2024 VS 2031

Figure 4. Antisense Oligonucleotide Features

Figure 5. Aptamer Features

Figure 6. Other Features

Figure 7. Global Antisense and RNAi Therapeutics Drug Market Size by Application (2020-2031) & (US$ Million)

Figure 8. Global Antisense and RNAi Therapeutics Drug Market Share by Application: 2024 VS 2031

Figure 9. Neuromuscular Diseases Case Studies

Figure 10. ATTR Case Studies

Figure 11. Hepatic VOD Case Studies

Figure 12. Other Case Studies

Figure 13. Antisense and RNAi Therapeutics Drug Report Years Considered

Figure 14. Global Antisense and RNAi Therapeutics Drug Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 15. Global Antisense and RNAi Therapeutics Drug Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 16. Global Antisense and RNAi Therapeutics Drug Market Share by Region: 2024 VS 2031

Figure 17. Global Antisense and RNAi Therapeutics Drug Market Share by Players in 2024

Figure 18. Global Top Antisense and RNAi Therapeutics Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Antisense and RNAi Therapeutics Drug as of 2024)

Figure 19. The Top 10 and 5 Players Market Share by Antisense and RNAi Therapeutics Drug Revenue in 2024

Figure 20. North America Antisense and RNAi Therapeutics Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 21. North America Antisense and RNAi Therapeutics Drug Market Share by Country (2020-2031)

Figure 22. United States Antisense and RNAi Therapeutics Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 23. Canada Antisense and RNAi Therapeutics Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 24. Europe Antisense and RNAi Therapeutics Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 25. Europe Antisense and RNAi Therapeutics Drug Market Share by Country (2020-2031)

Figure 26. Germany Antisense and RNAi Therapeutics Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 27. France Antisense and RNAi Therapeutics Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 28. U.K. Antisense and RNAi Therapeutics Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. Italy Antisense and RNAi Therapeutics Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. Russia Antisense and RNAi Therapeutics Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. Nordic Countries Antisense and RNAi Therapeutics Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 32. Asia-Pacific Antisense and RNAi Therapeutics Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 33. Asia-Pacific Antisense and RNAi Therapeutics Drug Market Share by Region (2020-2031)

Figure 34. China Antisense and RNAi Therapeutics Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 35. Japan Antisense and RNAi Therapeutics Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. South Korea Antisense and RNAi Therapeutics Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. Southeast Asia Antisense and RNAi Therapeutics Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. India Antisense and RNAi Therapeutics Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. Australia Antisense and RNAi Therapeutics Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 40. Latin America Antisense and RNAi Therapeutics Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 41. Latin America Antisense and RNAi Therapeutics Drug Market Share by Country (2020-2031)

Figure 42. Mexico Antisense and RNAi Therapeutics Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 43. Brazil Antisense and RNAi Therapeutics Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 44. Middle East & Africa Antisense and RNAi Therapeutics Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 45. Middle East & Africa Antisense and RNAi Therapeutics Drug Market Share by Country (2020-2031)

Figure 46. Turkey Antisense and RNAi Therapeutics Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 47. Saudi Arabia Antisense and RNAi Therapeutics Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 48. UAE Antisense and RNAi Therapeutics Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 49. Biogen Revenue Growth Rate in Antisense and RNAi Therapeutics Drug Business (2020-2025)

Figure 50. Sarepta Therapeutics Revenue Growth Rate in Antisense and RNAi Therapeutics Drug Business (2020-2025)

Figure 51. Jazz Pharmaceuticals Revenue Growth Rate in Antisense and RNAi Therapeutics Drug Business (2020-2025)

Figure 52. Bausch & Lomb Revenue Growth Rate in Antisense and RNAi Therapeutics Drug Business (2020-2025)

Figure 53. Alnylam Pharmaceuticals Revenue Growth Rate in Antisense and RNAi Therapeutics Drug Business (2020-2025)

Figure 54. Dynavax Technologies Revenue Growth Rate in Antisense and RNAi Therapeutics Drug Business (2020-2025)

Figure 55. Kastle therapeutics Revenue Growth Rate in Antisense and RNAi Therapeutics Drug Business (2020-2025)

Figure 56. Akcea Therapeutics Revenue Growth Rate in Antisense and RNAi Therapeutics Drug Business (2020-2025)

Figure 57. Bottom-up and Top-down Approaches for This Report

Figure 58. Data Triangulation

Figure 59. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Antisense and RNAi Therapeutics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Oligonucleotide Therapeutics Market Research Report 2024

Oligonucleotide Therapy Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Antisense and RNA Interference Therapeutics Market Research Report 2024

Oligonucleotide based Therapies Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Oligonucleotide Drugs ONs Market Research Report 2025

Antisense Oligonucleotide ASO Therapeutics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Antisense oligonucleotides ASO Drug and siRNA Drug Market Research Report 2024

Global Peptide and Oligonucleotide Drugs Market Research Report 2024

Global Oligonucleotide Oligo Drugs Market Research Report 2024

Global Antisense Oligonucleotides ASO Therapy Market Research Report 2024

Global Nucleic Acid Drugs Market Research Report 2025

Global RNA Interference RNAi Based Therapeutics Market Research Report 2024

Global Oligonucleotide based Therapy Medicinal Product Market Research Report 2024

Global Antisense Therapy Market Research Report 2024

Global Oligonucleotide Therapy based Drug Market Research Report 2024

Global Antisense Oligonucleotide Therapy for the Nervous System Market Research Report 2024

Global Antisense Oligonucleotides ASO Drug Market Research Report 2024

Global Antisense Oligonucleotides based Therapeutics Market Research Report 2024

RELATED REPORTS

Global Pharma and Healthcare Social Media Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-14Y6812

Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Food Additives Testing Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-34O3983

Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Gabapentin API Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-9V17601

Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Electronic Informed Consent Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-22C17047

Fri Sep 12 00:00:00 UTC 2025

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions